Related references
Note: Only part of the references are listed.IL-6: Regulator of Treg/Th17 balance
Akihiro Kimura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Current Views on the Roles of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis
Mohamed El-behi et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
OCULAR MYASTHENIA GRAVIS IN A SENIOR POPULATION: DIAGNOSIS, THERAPY, AND PROGNOSIS
Jeffrey A. Allen et al.
MUSCLE & NERVE (2010)
Research advancement in immunopathogenesis of myasthenia gravis
Sha Huang et al.
NEUROSCIENCE BULLETIN (2010)
Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
Verena Brucklacher-Waldert et al.
BRAIN (2009)
Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis
J. -H. Yeh et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis
Lili Mu et al.
IMMUNOLOGY (2009)
CORRELATING EXTENT OF NEUROMUSCULAR INSTABILITY WITH ACETYLCHOLINE RECEPTOR ANTIBODIES
Maria E. Farrugia et al.
MUSCLE & NERVE (2009)
Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus
Agnes Doreau et al.
NATURE IMMUNOLOGY (2009)
A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis
Samia Ragheb et al.
ARCHIVES OF NEUROLOGY (2008)
Serum BAFF expression in patients with myasthenia gravis
Jee Young Kim et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Development of generalized disease at 2 years in patients with ocular myrasthenia gravis
MJ Kupersmith et al.
ARCHIVES OF NEUROLOGY (2003)
Share Paper
